Patents by Inventor Sarah Sanders

Sarah Sanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240074898
    Abstract: Various examples are provided related to electrosurgical devices which can be used during ab interno canaloplasty or pupilloplasty surgery. In one example, a suture tensioning and electrocautery device includes a casing; suture grips protruding out of a proximal end of the casing; a suture tensioning and retracting system connected to the suture grips; and a suture electrocautery system. In another example, a method includes affixing ends of a suture to respective suture grips protruding out of a proximal end of a suture tensioning and electrocautery device; tying the ends of the suture and tensioning the suture by rotating the suture grips to dilate Schlemm's canal; and heating the tied ends of the suture to maintain the tensioning of the suture thereby sustaining dilation of the Schlemm's canal.
    Type: Application
    Filed: April 26, 2023
    Publication date: March 7, 2024
    Inventors: Joel PALKO, Ali RAI, Maryam BUDARIS, Justin ROBINSON, Dakota SANDERS, Sarah WESTFALL
  • Publication number: 20220135920
    Abstract: An intravaginal culture device includes an outer housing configured for vaginal insertion. The outer housing includes an upper portion that removably couples with a lower portion. A first inner vessel is located at the upper portion and is configured to house a first plurality of embryos. A second inner vessel is located at the lower portion and is configured to house a second plurality of embryos.
    Type: Application
    Filed: October 22, 2021
    Publication date: May 5, 2022
    Applicant: REPROHEALTH TECHNOLOGIES, INC.
    Inventors: James Donahue, Michael Whitt, Katherine Russell, Christina Nicole Harrison, Sarah Sanders
  • Publication number: 20170081322
    Abstract: RNA polymerase I (Pol I) is a dedicated polymerase for the transcription of the 47S ribosomal RNA precursor subsequently processed into the mature 5.8S, 18S and 28S ribosomal RNAs and assembled into ribosomes in the nucleolus. Pol I activity is commonly deregulated in human cancers. Based on the discovery of lead molecule BMH-21, a series of pyridoquinazolinecarboxamides were synthesized as inhibitors of Pol I and activators of the destruction of RPA194, the Pol I large catalytic subunit protein. The present invention identifies a set of bioactive compounds, including purified stereoisomers, that potently cause RPA194 degradation that function in a tightly constrained chemical space. Pharmaceutical compositions comprising these compounds and their uses in cancer and other Pol I related diseases is also provided.
    Type: Application
    Filed: March 20, 2015
    Publication date: March 23, 2017
    Inventors: Marikki Laiho, Laureen Colis, James C. Barrow, Glen Ernst, Sarah Sanders
  • Publication number: 20150367785
    Abstract: A carrier device for removably coupling to a vehicle hitch for supporting a carrier is provided. The carrier device includes a hitch connector and a riser support coupled to the hitch connector. A cross support is coupled to the riser support and configured to move between a first position and a second position. The cross support includes a pair of arms configured to couple to the carrier.
    Type: Application
    Filed: June 17, 2015
    Publication date: December 24, 2015
    Inventor: Sarah Sanders